| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
in00002492448 |
| 005 |
20211202191529.0 |
| 006 |
m d f |
| 007 |
cr an||||||||| |
| 008 |
090504s2007 mdu sb f000 0 eng d |
| 035 |
|
|
|a (OCoLC)ocn320129179
|
| 040 |
|
|
|a GPO
|c GPO
|d GPO
|d MvI
|d UtOrBLW
|
| 049 |
|
|
|a WWW
|
| 074 |
|
|
|a 0499-T-02 (online)
|
| 086 |
0 |
|
|a HE 20.4802:P 69/2
|
| 245 |
0 |
0 |
|a Guidance for industry :
|b considerations for plasmid DNA vaccines for infectious disease indications.
|
| 246 |
3 |
0 |
|a Considerations for plasmid DNA vaccines for infectious disease indications
|
| 264 |
|
1 |
|a Rockville, MD :
|b U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,
|c [2007]
|
| 300 |
|
|
|a i, 11 pages :
|b digital, PDF file.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 538 |
|
|
|a Mode of access: Internet at the FDA CBER web site. Address as of 5/0409: http://www.fda.gov/cber/gdlns/plasdnavac.pdf ; current access is available via PURL.
|
| 500 |
|
|
|a Title from PDF title page (viewed on May 4, 2009).
|
| 500 |
|
|
|a "November 2007".
|
| 504 |
|
|
|a Includes bibliographical references (pages 9-11).
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Plasmids
|x Genetics.
|
| 650 |
|
0 |
|a Infection.
|
| 650 |
|
0 |
|a Vaccines
|z United States
|x Testing.
|
| 710 |
2 |
|
|a Center for Biologics Evaluation and Research (U.S.)
|
| 856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/LPS112199
|t 0
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 115f62fe-2c4b-38a2-a794-a531e9f83866
|i cc93d0d4-920b-3b8e-a6ad-e73d0b221653
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e HE 20.4802:P 69/2
|h Superintendent of Documents classification
|
| 998 |
f |
f |
|a HE 20.4802:P 69/2
|t 0
|l Available Online
|